Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
29.05 INR
8.39 B INR
72.27 B INR
68.16 M
About Jubilant Pharmova Limited
Sector
Industry
Website
Headquarters
Noida
Founded
1978
ISIN
INE700A01033
FIGI
BBG000D1Q1V7
Jubilant Pharmova Ltd. engages in the provision of basic organic chemicals. It operates through the following segments: Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation, Generics, and Proprietary Novel Drugs. The Radiopharma segment is involved in products for diagnosis and treatment of various diseases, including Pulmonary Embolism, Cancer, Coronary Artery Diseaseand many others. The Allergy Immunotherapy segment provides diagnostic devices for skin testing. The CDMO Sterile Injectables segment offer manufacturing services including sterile fill and finish injectables, full-service ophthalmic offer, and ampoules. The Generics segment includes development, manufacturing, distribution, sales and marketing of generics formulations. The CRDMO segment relates to drug discovery and development services. The company was founded on June 21, 1978 and is headquartered in Noida, India.
Related stocks
Jubilant Price ActionAs of July 31, 2025, Jubilant Pharmova Ltd is trading around ₹1,236, showing strong bullish momentum with gains of over 7% in recent sessions. The stock has recovered well from lower levels near ₹1,170 seen earlier, with sustained buyer interest and solid volume support. Technical indicators reveal
JUBILANT PHARMOVA- Bullish Flag & Pole Breakout (Daily T/F)Trade Setup
📌 Stock: JUBILANT PHARMOVA ( NSE:JUBLPHARMA )
📌 Trend: Strong Bullish Momentum
📌 Risk-Reward Ratio: 1:3 (Favorable)
🎯 Entry Zone: ₹1470.00 (Breakout Confirmation)
🛑 Stop Loss: ₹1058.00 (Daily Closing Basis) (-9.5 % Risk)
🎯 Target Levels:
₹1221.15
₹1269.55
₹1319.90
₹1373.55
₹1433.55
₹
Jubilant Pharmova – Approaching Critical Breakout Zone🔍 Key Observations
The stock has staged a strong rally from the ₹870 support zone and is now testing a critical resistance around ₹1,075–₹1,140.
This resistance zone is previously marked as a “Demand turned Supply” area – a major structure where price broke down earlier, and supply emerged.
Th
JUBLPHARMA Ready for an Up Move?Hello fellow traders, I hope you are all doing well.
Key Observations:
1. Strong Support Zone: JUBLPHARMA has reached a strong zone that previously acted as resistance and could now turn into support.
2. Chart Pattern: A falling wedge pattern is visible, which is typically a bullish rever
Bullish harmonic in jublpharma in Time frame- DAILYSpotted- Bullish harmonic in jublpharma in Time frame- DAILY
Observe whether it respects the harmonic levels.
Study-Practice-sharing
Educational purpose only.
This is not a recommendation -
I am not SEBI registered - Do not TRADE/INVEST based on what I publish here.
I am not responsible for your
Jubilant Pharmova cmp 1045.00 by Daily Chart viewJubilant Pharmova cmp 1045.00 by Daily Chart view
- Support Zone at 912 to 928 Price Band
- Resistance Zone at 1043 to 1065 Price Band
- Falling Price Channel Breakout and Rising Price Channel is in progress
- Daily Support at 970 > 898 > 815 with Resistance at 1115 > 1194 > 1243 > ATH 1309.90
JUBLPHARMA Trade set up 1:14+Jubilant Pharmova Limited (JUBLPHARMA) is currently showing a **bullish technical setup** with several key observations:
**Current Price and Movement**
- The stock is trading at 854.85 INR, up by 9.75 INR (+1.15%)
- The stock has experienced a significant upward movement
**Technical Highlights**
-
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of JUBLPHARMA is 1,079.80 INR — it has increased by 0.35% in the past 24 hours. Watch Jubilant Pharmova Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Jubilant Pharmova Limited stocks are traded under the ticker JUBLPHARMA.
JUBLPHARMA stock has fallen by −2.79% compared to the previous week, the month change is a −3.23% fall, over the last year Jubilant Pharmova Limited has showed a −12.30% decrease.
We've gathered analysts' opinions on Jubilant Pharmova Limited future price: according to them, JUBLPHARMA price has a max estimate of 1,500.00 INR and a min estimate of 1,206.00 INR. Watch JUBLPHARMA chart and read a more detailed Jubilant Pharmova Limited stock forecast: see what analysts think of Jubilant Pharmova Limited and suggest that you do with its stocks.
JUBLPHARMA reached its all-time high on Nov 7, 2024 with the price of 1,309.90 INR, and its all-time low was 51.55 INR and was reached on Sep 30, 2003. View more price dynamics on JUBLPHARMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
JUBLPHARMA stock is 1.71% volatile and has beta coefficient of 1.35. Track Jubilant Pharmova Limited stock price on the chart and check out the list of the most volatile stocks — is Jubilant Pharmova Limited there?
Today Jubilant Pharmova Limited has the market capitalization of 170.80 B, it has decreased by −1.41% over the last week.
Yes, you can track Jubilant Pharmova Limited financials in yearly and quarterly reports right on TradingView.
Jubilant Pharmova Limited is going to release the next earnings report on Oct 31, 2025. Keep track of upcoming events with our Earnings Calendar.
JUBLPHARMA earnings for the last quarter are 6.50 INR per share, whereas the estimation was 6.40 INR resulting in a 1.56% surprise. The estimated earnings for the next quarter are 6.85 INR per share. See more details about Jubilant Pharmova Limited earnings.
Jubilant Pharmova Limited revenue for the last quarter amounts to 19.01 B INR, despite the estimated figure of 18.87 B INR. In the next quarter, revenue is expected to reach 19.28 B INR.
JUBLPHARMA net income for the last quarter is 1.03 B INR, while the quarter before that showed 1.54 B INR of net income which accounts for −33.01% change. Track more Jubilant Pharmova Limited financial stats to get the full picture.
Yes, JUBLPHARMA dividends are paid annually. The last dividend per share was 5.00 INR. As of today, Dividend Yield (TTM)% is 0.47%. Tracking Jubilant Pharmova Limited dividends might help you take more informed decisions.
Jubilant Pharmova Limited dividend yield was 0.56% in 2024, and payout ratio reached 9.44%. The year before the numbers were 0.88% and 102.79% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 18, 2025, the company has 6.09 K employees. See our rating of the largest employees — is Jubilant Pharmova Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Jubilant Pharmova Limited EBITDA is 12.12 B INR, and current EBITDA margin is 14.42%. See more stats in Jubilant Pharmova Limited financial statements.
Like other stocks, JUBLPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Jubilant Pharmova Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Jubilant Pharmova Limited technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Jubilant Pharmova Limited stock shows the buy signal. See more of Jubilant Pharmova Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.